
Scientific Program
Opening Ceremony & Keynote Forum
Opening Ceremony Time: 09:00-09:20, Sept. 25, 2021 |
Keynote Forum Time: 09:20-12:00, Sept. 25, 2021 |
|
Moderator |
TBD |
Time |
Speeches and Speakers |
09:20-09:30 |
Moderator’s Introduction |
09:30-09:55 |
Title: TBD |
09:55-10:20 |
Title: TBD |
10:20-10:45 |
Title: The Application of Prodrug Technology in the Discovery of New Drugs with Enhancement |
10:45-11:10 |
Title: Cell Therapy for Kras-driven Cancer |
11:10-11:35 |
Title: TBD Dr. Yongcong Tan, Senior Director, Sanyou Biopharmaceuticals Co., Ltd., China |
11:35-12:00 |
Speech Opportunity Reserved |
Nexus 1: Philosophy of Life’s Carriers
Nexus 1-1: Novel Protein Expression Systems and Post Translational Modifications |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:00 |
Speech Opportunity Available |
14:00-14:25 |
Title: TBD |
14:25-14:50 |
Speech Opportunity Available |
14:50-15:15 |
Speech Opportunity Available |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Speech Opportunity Available |
15:55-16:20 |
Speech Opportunity Available |
16:20-16:45 |
Speech Opportunity Available |
16:45-17:10 |
Speech Opportunity Available |
Nexus 1-2: Frontiers of Protein Structures, Self-Assembly and Functions |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Speech Opportunity Available |
09:00-09:25 |
Speech Opportunity Available |
09:25-09:50 |
Title: Improving Agricultural Traits in Wheat by Tapping Natural Genetic Variations and Modulating Leaf Surface Features |
09:50-10:15 |
Title: The Essence of NAC Gene Family to the Cultivation of Drought-Resistant Soybean (Glycine Max L. Merr.) Cultivars |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Speech Opportunity Available |
10:55-11:20 |
Speech Opportunity Available |
11:20-11:45 |
Speech Opportunity Available |
11:45-12:10 |
Speech Opportunity Available |
Nexus 1-3: Protein-Protein, Protein-DNA/RNA Interactions |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:00 |
Speech Opportunity Available |
14:00-14:25 |
Speech Opportunity Available |
14:25-14:50 |
Title: Ribonucleoprotein Bodies in Epidermal Cells of Caragana Arborescens L. |
14:50-15:15 |
Speech Opportunity Available |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Speech Opportunity Available |
15:55-16:20 |
Title: Interplay between digests of glycated protein and gut microbiota |
16:20-16:45 |
Speech Opportunity Available |
16:45-17:10 |
Speech Opportunity Available |
Nexus 1-4: Protein Misfolding Diseases and Protein Degradation |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Speech Opportunity Available |
09:00-09:25 |
Speech Opportunity Available |
09:25-09:50 |
Speech Opportunity Available |
09:50-10:15 |
Title: Metalloproteinase Cargo in Circulating Exosomes in Related with Metabolic Marker in Colorectal Cancer Patients: New Approaches for Cancer Diagnosis |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Speech Opportunity Available |
10:55-11:20 |
Speech Opportunity Available |
11:20-11:45 |
Speech Opportunity Available |
11:45-12:10 |
Speech Opportunity Available |
Nexus 2: The Nature Is a Pharmacist or a Doctor
Nexus 2-1: New Proteins-based Drug Targets |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:00 |
Title: Fragment-Based Screening by NMR Demonstrates the Druggability of Non-Coding RNA of SARS CoV-2 |
14:00-14:25 |
Title: Antibody Engineering for Immobilized Enzyme Bioconjugation |
14:25-14:50 |
Title: TBD |
14:50-15:15 |
Title: TBD |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Speech Opportunity Available |
15:55-16:20 |
Speech Opportunity Available |
16:20-16:45 |
Speech Opportunity Available |
16:45-17:10 |
Speech Opportunity Available |
Nexus 2-2: Recombinant Plasma Protein Therapeutics |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Speech Opportunity Available |
09:00-09:25 |
Speech Opportunity Available |
09:25-09:50 |
Title: TBD |
09:50-10:15 |
Speech Opportunity Available |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Speech Opportunity Available |
10:55-11:20 |
Speech Opportunity Available |
11:20-11:45 |
Speech Opportunity Available |
11:45-12:10 |
Speech Opportunity Available |
Nexus 2-3: Protein as Biomarkers for Diagnostics |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:00 |
Speech Opportunity Available |
14:00-14:25 |
Title: Structure Fingerprint for Protein Folding |
14:25-14:50 |
Title: The Role of STAT1 and TNF- in Aging Process and Drug-Resistant Epilepsy |
14:50-15:15 |
Speech Opportunity Available |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Speech Opportunity Available |
15:55-16:20 |
Title: Integrated Bioprocess Monitoring: from Analyzing Critical Variables Through Cellular Metabolic Profiling Dr. Cecilia R.C. Calado, Professor, Instituto Superior de Engenharia de Lisboa, Portugal |
16:20-16:45 |
Speech Opportunity Available |
16:45-17:10 |
Speech Opportunity Available |
Nexus 2-4: Protein Drugs for Genetic, Hormonal, Metabolic and Immunologic Disorders |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Title: The Evolution of Antibody Therapy: From Substitution to Immunomodulation and Monoclonal Immunotherapy Dr. Paul Imbach, Professor Emeritus, Medical Faculty of the University of Basel, Switzerland |
09:00-09:25 |
Title: TBD Dr. Gary R. McLean, Associate Professor, London Metropolitan University, UK |
09:25-09:50 |
Title: TBD |
09:50-10:15 |
Speech Opportunity Available |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Title: IgA Immunoglobulin and Other Mucosal Proteins: Impact on Mammalian Immunologic Homeostasis |
10:55-11:20 |
Title: TBD |
11:20-11:45 |
Title: TBD |
11:45-12:10 |
Speech Opportunity Available |
Nexus 2-5: Protein Therapy for Cancer & Hematological Disorders |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Speech Opportunity Available |
09:00-09:25 |
Title: Role of the novel Hif-regulated genes in human cancers |
09:25-09:50 |
Speech Opportunity Available |
09:50-10:15 |
Speech Opportunity Available |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Speech Opportunity Available |
10:55-11:20 |
Speech Opportunity Available |
11:20-11:45 |
Speech Opportunity Available |
11:45-12:10 |
Speech Opportunity Available |
Nexus 3: Art of ConstructingLiving Molecules
Nexus 3-1: Protein Designs Time: Afternoon, Sept. 25, 2021 |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:00 |
Speech Opportunity Available |
14:00-14:25 |
Speech Opportunity Available |
14:25-14:50 |
Title: Molecular polymorphism of human enzymes as the basis of individual sensitivity to drugs. Supercomputer-assisted modeling as a tool for analysis of structural changes and enzymatic activity of proteins |
14:50-15:15 |
Speech Opportunity Available |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Speech Opportunity Available |
15:55-16:20 |
Speech Opportunity Available |
16:20-16:45 |
Speech Opportunity Available |
16:45-17:10 |
Speech Opportunity Available |
Nexus 3-2: Screening, Selection Assays and Directed Evolution Time: Morning, Sept. 26, 2021 |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Speech Opportunity Available |
09:00-09:25 |
Speech Opportunity Available |
09:25-09:50 |
Speech Opportunity Available |
09:50-10:15 |
Speech Opportunity Available |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Speech Opportunity Available |
10:55-11:20 |
Speech Opportunity Available |
11:20-11:45 |
Speech Opportunity Available |
11:45-12:10 |
Speech Opportunity Available |
Nexus 3-3: Protein Engineering, Optimizing Expression and Purification Time: Afternoon, Sept. 26, 2021 |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:00 |
Speech Opportunity Available |
14:00-14:25 |
Speech Opportunity Available |
14:25-14:50 |
Title: Targeted Tagging-Based Proteomic Studies in Rice Dr. Yuming Lu, Shanghai Center for Plant Stress Biology, Chinese Academy of Sciences, China |
14:50-15:15 |
Speech Opportunity Available |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Speech Opportunity Available |
15:55-16:20 |
Speech Opportunity Available |
16:20-16:45 |
Speech Opportunity Available |
16:45-17:10 |
Speech Opportunity Available |
Nexus 4: New Paths to Life Science Breakthroughs
Nexus 4-1: Advances in Protein Chemistry and Structural Biology Time: Afternoon, Sept. 25, 2021 |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:00 |
Speech Opportunity Available |
14:00-14:25 |
Speech Opportunity Available |
14:25-14:50 |
Speech Opportunity Available |
14:50-15:15 |
Speech Opportunity Available |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Speech Opportunity Available |
15:55-16:20 |
Speech Opportunity Available |
16:20-16:45 |
Speech Opportunity Available |
16:45-17:10 |
Speech Opportunity Available |
Nexus 4-2: Next Generation Proteomics Time: Morning, Sept. 26, 2021 |
|
Chair |
Dr. Shao Chin Lee, Professor, Jiangsu Normal University, China |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Speech Opportunity Available |
09:00-09:25 |
Title: Centrosome Amplification in Cancer and Cancer-Associated Diseases |
09:25-09:50 |
Title: MAGEA1 Interacts with FBXW7 and Regulates Ubiquitin Ligase-Mediated Turnover of NICD1 in Breast and Ovarian Cancer Cells |
09:50-10:15 |
Title: The Mechanism Study of Myo1f Protein in Antifungal Signaling Pathway |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Speech Opportunity Available |
10:55-11:20 |
Title: Optimise Your Small Scale Cultivations and Scale Up Process by Using the New Online Measuring Device Kuhner TOM |
11:20-11:45 |
Title: Pyrococcuuus Furiosus L-Asparaginase Mutants: A Promising Anti-Proliferative Chemotherapeutic Agent with Improved Efficacy and Stability Dr. Saurabh Bansal, Assistant Professor, Jaypee University of Information Technology, India |
11:45-12:10 |
Speech Opportunity Available |
Nexus 4-3: Membrane and Cellular Proteins and Peptides Time: Afternoon, Sept. 26, 2021 |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:00 |
Speech Opportunity Available |
14:00-14:25 |
Title: TBD |
14:25-14:50 |
Speech Opportunity Available |
14:50-15:15 |
Title: Antimicrobial Activity and Mechanism of Porcine Beta Defensin 2 |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Speech Opportunity Available |
15:55-16:20 |
Title: TBD |
16:20-16:45 |
Title: ORP4L Bridges Plasma Membrane PIP2 Metabolism To Mitochondria Oxidative Phosphorylation in Leukemia |
16:45-17:10 |
Speech Opportunity Available |
Nexus 5: Deep Mining the Treasure of Proteins and Peptides
Nexus 5-1: Protein/Peptide Chips and Microarrays Time: Afternoon, Sept. 25, 2021 |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:00 |
Speech Opportunity Available |
14:00-14:25 |
Speech Opportunity Available |
14:25-14:50 |
Speech Opportunity Available |
14:50-15:15 |
Speech Opportunity Available |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Speech Opportunity Available |
15:55-16:20 |
Speech Opportunity Available |
16:20-16:45 |
Speech Opportunity Available |
16:45-17:10 |
Speech Opportunity Available |
Nexus 5-2: Protein Nanotechnology Time: Morning, Sept. 26, 2021 |
|
Chair |
Dr. Yashwant V. Pathak, Professor & Associate Dean of Faculty Affairs, University of South Florida, USA |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Speech Opportunity Available |
09:00-09:25 |
Title: Challenges in Delivering the Peptide Vaccine and Possible Use of Nano Emulsions to Avoid Antigenic Reactions |
09:25-09:50 |
Speech Opportunity Available |
09:50-10:15 |
Speech Opportunity Available |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Speech Opportunity Available |
10:55-11:20 |
Speech Opportunity Available |
11:20-11:45 |
Speech Opportunity Available |
11:45-12:10 |
Speech Opportunity Available |
Nexus 5-3: Frontier of Peptide Chemistry and Biology Time: Afternoon, Sept. 26, 2021 |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:00 |
Speech Opportunity Available |
14:00-14:25 |
Speech Opportunity Available |
14:25-14:50 |
Speech Opportunity Available |
14:50-15:15 |
Speech Opportunity Available |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Speech Opportunity Available |
15:55-16:20 |
Speech Opportunity Available |
16:20-16:45 |
Speech Opportunity Available |
16:45-17:10 |
Speech Opportunity Available |
Nexus 5-4: Emerging Peptide-based Technologies Time: Morning, Sept. 27, 2021 |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Speech Opportunity Available |
09:00-09:25 |
Speech Opportunity Available |
09:25-09:50 |
Speech Opportunity Available |
09:50-10:15 |
Speech Opportunity Available |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Speech Opportunity Available |
10:55-11:20 |
Speech Opportunity Available |
11:20-11:45 |
Speech Opportunity Available |
11:45-12:10 |
Speech Opportunity Available |
Nexus 5-5: Protein & Peptides Therapeutics R & D Time: Morning, Sept. 27, 2021 |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Speech Opportunity Available |
09:00-09:25 |
Speech Opportunity Available |
09:25-09:50 |
Speech Opportunity Available |
09:50-10:15 |
Speech Opportunity Available |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Speech Opportunity Available |
10:55-11:20 |
Speech Opportunity Available |
11:20-11:45 |
Speech Opportunity Available |
11:45-12:10 |
Speech Opportunity Available |
Nexus 6: Young Experts Forum
Nexus 6: Young Experts Forum Time: Afternoon, Sept. 25, 2021 |
|
Chair |
Call for Chair |
Co-chair |
Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:00 |
Title: Resverotrol Attenuates Centrosome Amplification by Inhibiting PKCα Pathway |
14:00-14:25 |
Title: The Binding Between ROCK1 and DCTN2 Signals for the Diabetes-Associated Centrosome Amplification in Colon Cancer Cells |
14:25-14:50 |
Title: Periplognenin and Levistolide A Inhibit the Growth of Gastric Cancer Cells in vitro and in vivo |
14:50-15:15 |
Title: Hexavalent Chromium Induces Centrosome Amplification by Activating ATF6 |
15:15-15:30 |
Coffee Break |
15:30-15:55 |
Speech Opportunity Available |
15:55-16:20 |
Title: MAGEA1 Inhibits the Expression of BORIS via Increased Promoter Methylation |
16:20-16:45 |
Speech Opportunity Available |
16:45-17:10 |
Speech Opportunity Available |
Information Research Center of International Talent, Ministry of Science and Technology, China
![]() |
©2008-2021 All rights reserved by BIT Congress Inc. Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629 |